weight loss plateau strategies glp-1 medication plateaus on medications are extremely common, but usually not for the reasons you'd think. Many patients get prescribed and sent home to figure out the rest on their own The New Weight Management Meds

Summary comparison table Quick read: semaglutide remains the validated pillar with cardiovascular backing, tirzepatide dominates weight efficacy on solid data, and retatrutide pushes the frontier further at the cost of a dossier still consolidating

J Diabetes Complicat 26(5):458459

Pausing my subscription so I could catch up with my supply was easy to do via the website

The trial ran for a little over a year and showed an average decrease in BMI of 16% (compared to 0.6% for placebo)

Approximately 2429% average weight reduction

That guideline reinforces the need to treat GLP-1 medicine use as part of broader professional care